United States
US 12,697,397 B2
Modified adeno-associated virus vectors and delivery thereof into the central nervous system
US 12,697,397 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-04. Applicant: Coave Therapeutics. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- Coave Therapeutics
- Inventors
- Philippe Moullier; Willem Broekaert
- Publication date
- 2026-08-04
- Filing date
- 2022-06-24
- Document type
- B2 Granted patent
- Also written as
- US 12,697,397 B2 · US12697397 · 12697397
Abstract
The present invention relates to modified adeno-associated virus (AAV) vectors for use in transducing a cell in the central nervous system (CNS) of a subject, and for use in the prevention or treatment of a CNS disease. In particular, the modified AAV vectors according to the present invention comprise at least one surface-bound saccharide, and are to be administered directly to the CNS but not intracerebroventricularly.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free